Concerning APOA4, several proteomics studies have identified low levels, which were associated with various forms of cancer, including epithelial ovarian, hepatocellular, pancreatic, oral and papillary thyroid carcinoma [109,116,117,118]. Here, APOA4 is linked to differentiated thyroid carcinoma.